Joseph Frattaroli serves as Executive at Inhibikase Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Joseph Frattaroli has executed 2 insider transactions totaling $2.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 19, 2022 involved purchasing 3,948 shares valued at $2.5K.
Joseph Frattaroli currently holds 48,091 shares of Inhibikase Therapeutics, Inc. (IKT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph Frattaroli has been a net buyer of IKT stock. They have purchased $2.5K and sold $0 worth of shares.
Joseph Frattaroli's most recent insider trade was on May 19, 2022, when they purchased 3,948 shares at $0.64 per share.
Get notified when new Form 4 filings are submitted
| $10.00 |
| Discretionary |